Realheart’s CEO in Filmed Company Presentation: “the biggest news for 2022 is that the clinical version of Realheart® TAH is fully developed and under production”

In a filmed presentation on the occasion of Realheart's Annual General Meeting, CEO Ina Laura Perkins describes what the company has done during the past year and what is in the pipeline for 2022.

Among other things, Ina Laura explains what the four key factors for success are and why the Company has started a subsidiary in Australia.

Link to the Filmed Presentation: https://youtu.be/DQAErlgdRBE